PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Ompi and Balda are pleased to announce that they will be exhibiting at CPhI Worldwide 2017 at Messe Frankfurt (24th-26th October), at Booth 42H12!

Ompi is part of the Pharmaceutical Systems division of Stevanato Group. It boasts a unique expertise in providing superior pharmaceutical containers from glass-tubing. Its comprehensive portfolio covers every customer needs, from those related to small molecules to highly sensitive drugs: syringes, pen and dental cartridges, injection and lyophilization vials and ampoules. Syringes, cartridges and vials are produced both in bulk and sterile format (EZ-fillTM).
Ompi also provides customized glass containers, all manufactured to the highest standards.
Balda is one of the leading global worldwide manufacturers customized healthcare products made of plastics. It provides life cycle competence from product design, development, industrialization, regulatory approvals, series production and global supply chain management up to continuous improvement programs.
Thanks to their expertise, Stevanato Group can combine glass processing expertise together with plastic injection molding as well as device technology to provide complete solutions to help patients in their daily lives.
A successful result of this synergy is the Ompi EZ-fill® ISS. It’s an innovative fully passive safety system designed to guarantee end users’ safety and reduce total cost of ownership for the pharmaceutical companies. ISS is the first development within the platform licensed by Tip-Top, a primary designer of proprietary safety needle stick protection devices and technologies. Based on their mini-Max design, Ompi EZ-fill® ISS avoids piercing after rubber needle shield removal, providing an end-user experience similar to a standard syringe.
 www.stevanatogroup.com

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026